162 related articles for article (PubMed ID: 37179317)
1. An exploratory study for tuft cells in the breast and their relevance in triple-negative breast cancer: the possible relationship of SOX9.
Yamada Y; Simon R; Iwane K; Nakanishi Y; Takeuchi Y; Yoshizawa A; Takada M; Toi M; Haga H; Marx A; Sauter G
BMC Cancer; 2023 May; 23(1):438. PubMed ID: 37179317
[TBL] [Abstract][Full Text] [Related]
2. A Tuft Cell-Like Signature Is Highly Prevalent in Thymic Squamous Cell Carcinoma and Delineates New Molecular Subsets Among the Major Lung Cancer Histotypes.
Yamada Y; Simon-Keller K; Belharazem-Vitacolonnna D; Bohnenberger H; Kriegsmann M; Kriegsmann K; Hamilton G; Graeter T; Preissler G; Ott G; Roessner ED; Dahmen I; Thomas RK; Ströbel P; Marx A
J Thorac Oncol; 2021 Jun; 16(6):1003-1016. PubMed ID: 33609752
[TBL] [Abstract][Full Text] [Related]
3. POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer.
Huang YH; Klingbeil O; He XY; Wu XS; Arun G; Lu B; Somerville TDD; Milazzo JP; Wilkinson JE; Demerdash OE; Spector DL; Egeblad M; Shi J; Vakoc CR
Genes Dev; 2018 Jul; 32(13-14):915-928. PubMed ID: 29945888
[TBL] [Abstract][Full Text] [Related]
4. Tuft cell-like carcinomas: novel cancer subsets present in multiple organs sharing a unique gene expression signature.
Yamada Y; Bohnenberger H; Kriegsmann M; Kriegsmann K; Sinn P; Goto N; Nakanishi Y; Seno H; Chigusa Y; Fujimoto M; Minamiguchi S; Haga H; Simon R; Sauter G; Ströbel P; Marx A
Br J Cancer; 2022 Nov; 127(10):1876-1885. PubMed ID: 35999270
[TBL] [Abstract][Full Text] [Related]
5. SOX9 Is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis.
Ma Y; Shepherd J; Zhao D; Bollu LR; Tahaney WM; Hill J; Zhang Y; Mazumdar A; Brown PH
Mol Cancer Res; 2020 Dec; 18(12):1825-1838. PubMed ID: 32661114
[TBL] [Abstract][Full Text] [Related]
6. Molecular Classification of Extrapulmonary Neuroendocrine Carcinomas With Emphasis on POU2F3-positive Tuft Cell Carcinoma.
Koh J; Kim H; Moon KC; Lee C; Lee K; Ryu HS; Jung KC; Jeon YK
Am J Surg Pathol; 2023 Feb; 47(2):183-193. PubMed ID: 36253891
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of epithelial–mesenchymal transition and stem cell markers in intrinsic subtypes of breast cancer.
Pomp V; Leo C; Mauracher A; Korol D; Guo W; Varga Z
Breast Cancer Res Treat; 2015 Nov; 154(1):45-55. PubMed ID: 26467042
[TBL] [Abstract][Full Text] [Related]
8. POU2F3 beyond thymic carcinomas: expression across the spectrum of thymomas hints to medullary differentiation in type A thymoma.
Yamada Y; Sugimoto A; Hoki M; Yoshizawa A; Hamaji M; Date H; Haga H; Marx A
Virchows Arch; 2022 Apr; 480(4):843-851. PubMed ID: 34988657
[TBL] [Abstract][Full Text] [Related]
9. Triple-Negative Breast Cancer: A Comprehensive Study of Clinical, Histomorphological, and Immunohistochemical Features in Indian Patients.
Sable M; Pai TD; Shet T; Patil A; Dhanavade S; Desai SB
Int J Surg Pathol; 2017 May; 25(3):230-237. PubMed ID: 27612858
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of Smurf2, a tumor-suppressive ubiquitin ligase, in triple-negative breast cancers: involvement of the RB-microRNA axis.
Liu X; Gu X; Sun L; Flowers AB; Rademaker AW; Zhou Y; Kiyokawa H
BMC Cancer; 2014 Feb; 14():57. PubMed ID: 24485087
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and Prognostic Significances of SOX9 in Thymic Epithelial Tumor.
Yuan X; Huang L; Luo W; Zhao Y; Nashan B; Yu F; Liu Y
Front Oncol; 2021; 11():708735. PubMed ID: 34778027
[TBL] [Abstract][Full Text] [Related]
12. In search of triple-negative DCIS: tumor-type dependent model of breast cancer progression from DCIS to the invasive cancer.
Kurbel S
Tumour Biol; 2013 Feb; 34(1):1-7. PubMed ID: 23208673
[TBL] [Abstract][Full Text] [Related]
13. Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer.
Bryan BB; Schnitt SJ; Collins LC
Mod Pathol; 2006 May; 19(5):617-21. PubMed ID: 16528377
[TBL] [Abstract][Full Text] [Related]
14. Sirt6-mediated epigenetic modification of DNA accessibility is essential for Pou2f3-induced thymic tuft cell development.
Zhang Q; Zhang J; Lei T; Liang Z; Dong X; Sun L; Zhao Y
Commun Biol; 2022 Jun; 5(1):544. PubMed ID: 35668088
[TBL] [Abstract][Full Text] [Related]
15. Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance.
Zhao S; Ma D; Xiao Y; Li XM; Ma JL; Zhang H; Xu XL; Lv H; Jiang WH; Yang WT; Jiang YZ; Zhang QY; Shao ZM
Oncologist; 2020 Oct; 25(10):e1481-e1491. PubMed ID: 32406563
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities.
Yamada Y; Belharazem-Vitacolonnna D; Bohnenberger H; Weiß C; Matsui N; Kriegsmann M; Kriegsmann K; Sinn P; Simon-Keller K; Hamilton G; Graeter T; Preissler G; Ott G; Schölch S; Nakajima N; Yoshizawa A; Haga H; Date H; Thomas RK; Petrini I; Giaccone G; Ströbel P; Marx A
Cell Death Dis; 2022 Nov; 13(11):979. PubMed ID: 36402755
[TBL] [Abstract][Full Text] [Related]
17. Expression of FOXI1 and POU2F3 varies among different salivary gland neoplasms and is higher in Warthin tumor.
Hoki M; Yamada Y; Hiratomo E; Hirata M; Takeuchi Y; Yoshimatsu M; Kikuchi M; Kishimoto Y; Marx A; Haga H
Discov Oncol; 2024 Feb; 15(1):36. PubMed ID: 38358561
[TBL] [Abstract][Full Text] [Related]
18. P16 and p53 play distinct roles in different subtypes of breast cancer.
Shan M; Zhang X; Liu X; Qin Y; Liu T; Liu Y; Wang J; Zhong Z; Zhang Y; Geng J; Pang D
PLoS One; 2013; 8(10):e76408. PubMed ID: 24146864
[TBL] [Abstract][Full Text] [Related]
19. Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer.
Wong H; Lau S; Leung R; Chiu J; Cheung P; Wong TT; Liang R; Epstein RJ; Yau T
Med Oncol; 2012 Sep; 29(3):1536-42. PubMed ID: 21983862
[TBL] [Abstract][Full Text] [Related]
20. OCA-T1 and OCA-T2 are coactivators of POU2F3 in the tuft cell lineage.
Wu XS; He XY; Ipsaro JJ; Huang YH; Preall JB; Ng D; Shue YT; Sage J; Egeblad M; Joshua-Tor L; Vakoc CR
Nature; 2022 Jul; 607(7917):169-175. PubMed ID: 35576971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
